Why is Gland Pharma falling/rising?

As of 08-Jul, Gland Pharma Ltd's stock price is currently at 1,890.00, reflecting an increase of 12.4, or 0.66%. The stock has been performing well recently, having outperformed its sector by 1.59% today and achieving consecutive gains over the last four days, with a total return of 1.27% during this period. Additionally, Gland Pharma has shown strong performance over the past month, with a return of 15.82%, while its year-to-date performance stands at 5.67%. The company benefits from a low debt-to-equity ratio and high institutional holdings at 40.18%, indicating strong investor confidence and capability in analyzing the company's fundamentals, which may contribute positively to its recent price movement.
In the broader market context, Gland Pharma's short-term return of 0.71% over the past week significantly outpaces the Sensex, which has only increased by 0.02% in the same timeframe. However, despite the positive price movements, there is a notable decline in investor participation, with delivery volume dropping by 62.72% against the five-day average, which could indicate a potential concern for future trading activity. Overall, while Gland Pharma's stock is currently rising, the decrease in liquidity and delivery volume may warrant caution among investors looking for sustained growth.